Cytomx Therapeutics

Get Full Access


  • CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody technology platform. The company uses the platform to create development-stage proprietary cancer immunotherapies against clinically-validated targets, as well as to develop first-in-class investigational cancer therapeutics against novel targets. CytomX believes that its Probody platform has the potential to improve the combined efficacy and safety profile of monoclonal antibody modalities, including cancer immunotherapies, antibody drug conjugates and T-cell-recruiting bispecific antibodies. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. Investigational Probody therapeutics are being developed that address clinically-validated cancer targets in immuno-oncology, such as PD-L1 against which our clinical candidate CX-072 is directed, as well as novel targets, such as CD-166, that are difficult to drug without causing damage to healthy tissues, or toxicities. In addition to its proprietary programs, CytomX is collaborating with strategic partners including Bristol-Myers Squibb Company, Pfizer Inc., MD Anderson Cancer Center and ImmunoGen, Inc. For more information, visit
  • location

    Headquarters:151 Oyster Point Boulevard , South San Francisco, California, United States

  • Cytomx Therapeutics phone

    Phone Number: +1 650-873-3861

  • Cytomx Therapeutics website


  • Cytomx Therapeutics employees


  • Cytomx Therapeutics revenue

    Revenue:$100 - 250M

  • Cytomx Therapeutics legal name

    Legal Name:Cytomx Therapeutics

  • Cytomx Therapeutics's Social Media

    Cytomx Therapeutics linkedin Cytomx Therapeutics twitter
  • done Is this data correct?
  • |  NAICS Code: 541713  |

    Show More
Person level website identification

CEO for Cytomx Therapeutics

Sean Mccarthy

President, Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Carlos Campoy

Chief Financial Officer

Amy Peterson

President And Chief Operating Officer

Jeff Landau

Chief Business Officer And Head Of Strategy

Alison Hannah

Senior Vice President And Chief Marketing Officer

Jennifer Richardson

Vice President, Pharmacology And Toxicology

Frequently Asked Questions regarding Cytomx Therapeutics

  • Where are Cytomx Therapeutics's Headquarters?

    Cytomx Therapeutics's Headquarters are in 151 Oyster Point Boulevard ,South San Francisco,California,United States

  • What is Cytomx Therapeutics's phone number?

    Cytomx Therapeutics's phone number is +1 650-873-3861

  • What is Cytomx Therapeutics's official website?

    Cytomx Therapeutics's official website is

  • What is Cytomx Therapeutics's Revenue?

    Cytomx Therapeutics's revenue is $100 - 250M

  • What is Cytomx Therapeutics's NAICS code?

    Cytomx Therapeutics's NAICS code is 541713

  • How many employees are working in Cytomx Therapeutics

    Cytomx Therapeutics has 149 employees

  • What is Cytomx Therapeutics's Industry?

    Cytomx Therapeutics is in the industry of Biotechnology

  • Who is Cytomx Therapeutics's CEO?

    Cytomx Therapeutics's CEO is Sean Mccarthy

Company Directory